Fatigue is a reported side effect for some GLP-1 receptor agonists, particularly at higher doses used for weight management
Your Precision Peptide Genetic Test examines variants like GLP1R rs6923761 and FTO rs9939609, which influence how efficiently your body processes peptide signals and metabolizes substances
A genetic test result showing lower GLP-1 receptor expression variants, combined with undertreated hypothyroidism, suggests your provider may recommend closer monitoring, higher starting doses, or dual-compound approaches like GLP-Squared
Conflict of interest S.M.: Advisory boards: AstraZeneca, Boehringer Ingelheim, Intarcia Therapeutics, Novo Nordisk, Sanofi, Abbott Lab, Bayer, Amgen
Mick is an optometrist and residency director at the San Francisco VA Medical Center, a clinical professor at UC Berkeley Herbert Wertheim School of Optometry and Vision Science and holds a volunteer faculty appointment at the UC San Francisco department of ophthalmology